CIP2A inhibits PP2A in human malignancies.
By M. Junttila, Pietri Puustinen, M. Niemelä, Raija Ahola, H. Arnold, Trine Böttzauw, R. Ala‐aho, C. Nielsen, J. Ivaska, Y. Taya and 10 more. Cell, 2007
633 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/d9a72c7b46714462de545c57d21abc825c3d32cc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- From promiscuity to precision: protein phosphatases get a makeover. (2009, background): “By contrast, PP1 inhibitors such as inhibitor-2, DARPP-32, and PHI-1 (Eto et al., 1999), and PP2A inhibitors including SET (Neviani et al., 2005) and CIP2A (Junttila et al., 2007), may utilize a different mode of phosphatase inhibition.”